OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
J. Mark Wiggins is owner and compendial consultant with Global Pharmacopoeia Solutions LLC.
Joseph A. Albanese is the director of Analytical Strategy and Compliance at Janssen Research and Development, LLC.
This article describes the revision process and the resulting publication of proposed and official updates for pharmacopoeias around the world.
Related Content:
Pharmacopoeial Compliance Series